News
All the latest news from Quadratech Diagnostics. If you would like to receive updates via our newsletter then please sign up here.
Showing Category: Haemostasis
Quadratech Diagnostics launches Factor-X Activator RVV-X globally
We are delighted to announce a global launch of Factor-X Activator RVV-X (50U) as the latest addition to the Q-TOX range of high quality toxins, antigens, antibodies, and virus-like particles (VLPs). Q-TOX RVV-X is a highly purified Factor X activating enzyme prepared from the Russell Viper Venom (Daboia russelii). Q-TOX RVV-X is available for research […]
Haemostasis January 2025 Journal Club
Keep informed about evolving science and clinical practice with our January 2025 compilation of the latest studies, guidelines, and perspectives in haemostasis. PERSPECTIVES & REVIEWS Albert CM. Oral anticoagulation in device patients with atrial high-rate episodes: Shared decision-making after ARTESIA and NOAH-AFNET-6. Circulation. 2024;150(18):1398-1400. doi:10.1161/CIRCULATIONAHA.124.068018 Bos MHA, van Diest RE, Monroe DM. Blood coagulation factor […]
Haemostasis November & December 2024 Industry News
Our round-up of the latest developments from across the haemostasis industry for November & December 2024, including key readouts at ASH2024 REGULATORY Vaderis Therapeutics’ VAD044 (AKT inhibitor) granted FDA Fast Track designation for the treatment of Hereditary Haemorrhagic Telangiectasia (HHT) (18 Nov) Kedrion Biopharma announced that the FDA approved the company’s manufacturing facility in Bolognana, […]
Haemostasis February & March 2025 Events
Explore some of the Workshops, Conferences, Webinars, and other Haemostasis events to mark in your diary in the coming months: Highlights of ASH – North America Where: Washington DC, US When: 31 January – February 1, 2025 69th Annual Meeting of the Society of Thrombosis and Haemostasis Research Where: Lausanne, Switzerland When: 18 February […]
Come Meet Us at the Joint BSHT NVTH ASM 2025!
COME MEET US We are delighted to announce we will be a proud sponsor and exhibitor at the upcoming Joint BSHT NVTH ASM (Annual Scientific Meeting) in Newcastle. We very much look forward to meeting those in attendance and will be happy to discuss our offering of diagnostic reagents and kits for the investigation of […]
Haemostasis December 2024 & January 2025 Events
Explore some of the Workshops, Conferences, Webinars, and other Haemostasis events to mark in your diary in the coming months: Thrombosis UK: Let’s Talk Clots 2024 Where: Virtual, On demand When: Access until 15 December, 2024 NBDF Webinar Advancing Hemophilia A Treatment: Latest Insights on FVIII Expression Durability and Gene Therapy Where: Virtual When: […]
Haemostasis October 2024 Journal Club
Keep informed about evolving science and clinical practice with our October 2024 compilation of the latest studies, guidelines, and perspectives in haemostasis.
Haemostasis November 2024 Upcoming Events
Explore some of the Workshops, Conferences, Webinars, and other Haemostasis events to mark in your diary for November 2024.
Haemostasis October 2024 Industry News
Stay up-to-speed with our monthly round-up of the latest developments from across the haemostasis industry.
Come Meet Us at the UK NEQAS Annual Scientific Meeting at Stand 2!
Quadratech Diagnostics are delighted to confirm that we will be exhibiting at the upcoming UK NEQAS Annual Scientific Meeting in Sheffield on 5th & 6th June 2024. We would love to talk to you so please drop by to stand 2 to say hello!
Assess, Quickly and Efficiently, the body’s Global Fibrinolytic Capacity with Lysis Timer
Investigate the global body’s fibrinolytic capacity by testing a plasma clot obtained by coagulation with thrombin and calcium in presence of silica and a defined amount of exogenous tissue plasminogen activator (tPA).
5-ELISA ADAMTS-13 Quantitative test for the determination of ADAMTS-13 antigen in human citrate plasma
5-Diagnostics’ 5-ELISA ADAMTS-13 Antigen one-step protocol is performed in 65 minutes!
